Micrainin en es it fr

Micrainin Brand names, Micrainin Analogs

Micrainin Brand Names Mixture

  • No information avaliable

Micrainin Chemical_Formula


Micrainin RX_link

No information avaliable

Micrainin fda sheet

Micrainin msds (material safety sheet)

Micrainin Synthesis Reference

No information avaliable

Micrainin Molecular Weight

309.469 g/mol

Micrainin Melting Point

< 25 oC

Micrainin H2O Solubility

Soluble as HCl salt

Micrainin State


Micrainin LogP


Micrainin Dosage Forms

Tablets (oral, 1 mg)

Micrainin Indication

Used for the symptomatic treatment of parkinsonism.

Micrainin Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Micrainin Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Micrainin side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Micrainin Patient Information

Micrainin Organisms Affected

Humans and other mammals